PCV55 - Cost-Utility Analysis of Angiotensin Receptor–Neprilysin Inhibitor Sacubitril/Valsartan Compared with Ace Inhibitors for the Treatment of Chronic Heart Failure in the United States

Saved in:
Bibliographic Details
Published inValue in health Vol. 19; no. 3; p. A49
Main Authors Harrington, RL, Zueger, PM, Kumar, VM, Rigoni, G, Atwood, AM, DiDomenico, RJ, Touchette, DR
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.05.2016
Online AccessGet full text

Cover

Loading…
More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2016.03.120